GSTM1 and colorectal carcinoma: Forty per cent of patients with CRC (6/15) who had f-Hb <10 μg/g presented with three or more of the symptoms listed in Table 3, but 68.7% of patients without CRC (1926/2803) had none or only one of these symptoms (p < 0.001).